Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 23, 2023
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
[ Wed, Aug 23rd 2023
] - WOPRAI
Tue, August 22, 2023
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
[ Tue, Aug 22nd 2023
] - WOPRAI
Oren Livnat Maintained (ANIP) at Strong Buy with Increased Target to $73 on, Aug 22nd, 2023
Oren Livnat of HC Wainwright & Co., Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $60 to $73 on, Aug 22nd, 2023.
Oren has made no other calls on ANIP in the last 4 months.
There are 3 other peers that have a rating on ANIP. Out of the 3 peers that are also analyzing ANIP, 0 agree with Oren's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Oren
- Gregory Fraser of "Truist Securities" Reiterated at Strong Buy and Held Target at $70 on, Monday, August 21st, 2023
- Vamil Divan of "Guggenheim" Maintained at Strong Buy with Increased Target to $72 on, Thursday, August 10th, 2023
- Elliot Wilbur of "Raymond James" Maintained at Buy with Increased Target to $49 on, Tuesday, May 9th, 2023
